Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sijongesonke Peter

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecules (Basel, Switzerland)|December 24, 2021
Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and MalariaSijongesonke Peter, Siphesihle Jama, Sibusiso Alven, et al.
Pharmaceutics|February 26, 2025
PEGylated Nanoliposomes Encapsulated with Anticancer Drugs for Breast and Prostate Cancer Therapy: An UpdateSijongesonke Peter, Vuyolwethu Khwaza, Sibusiso Alven, et al.
Pharmaceutics|June 27, 2025
Ferrocene-Based Hybrid Drugs as Potential Anticancer and Antibacterial Therapeutic Agents for Incorporation into Nanocarriers: In Silico, In Vitro, Molecular Docking EvaluationsSijongesonke Peter, Eric Morifi, Mutshinyalo Nwamadi, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecules (Basel, Switzerland)|December 24, 2021
Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and MalariaSijongesonke Peter, Siphesihle Jama, Sibusiso Alven, et al.
Pharmaceutics|February 26, 2025
PEGylated Nanoliposomes Encapsulated with Anticancer Drugs for Breast and Prostate Cancer Therapy: An UpdateSijongesonke Peter, Vuyolwethu Khwaza, Sibusiso Alven, et al.
Pharmaceutics|June 27, 2025
Ferrocene-Based Hybrid Drugs as Potential Anticancer and Antibacterial Therapeutic Agents for Incorporation into Nanocarriers: In Silico, In Vitro, Molecular Docking EvaluationsSijongesonke Peter, Eric Morifi, Mutshinyalo Nwamadi, et al.
Pageof 2